FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

371620002: Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3680598013 Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680599017 Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1196919012 Methenamine mandelate+sodium acid phosphate 300mg/500mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1210243016 Methenamine mandelate+sodium acid phosphate 300mg/500mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3468615015 Product containing methenamine mandelate 300 mg and sodium acid phosphate 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3485216015 Product containing methenamine mandelate 300 mg and sodium acid phosphate 500 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501103012 Methenamine mandelate 300 mg and sodium acid phosphate 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3567692010 Product containing only methenamine mandelate 300 mg and sodium acid phosphate 500 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3567693017 Product containing only methenamine mandelate 300 mg and sodium acid phosphate 500 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680598013 Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680599017 Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3680600019 Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Is a Product containing methenamine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methenamine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Is a Product containing methenamine mandelate and sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methenamine mandelate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sodium acid phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methenamine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monobasic sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has basis of strength substance (attribute) Methenamine mandelate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has basis of strength substance (attribute) Monobasic sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monobasic sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has basis of strength substance (attribute) Monobasic sodium phosphate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength numerator value 500 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Methenamine mandelate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has basis of strength substance (attribute) Methenamine mandelate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Is a Product containing methenamine and monobasic sodium phosphate (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has precise active ingredient Methenamine mandelate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has precise active ingredient Monobasic sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Plays role Laxative therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Is a Product containing only methenamine and monobasic sodium phosphate in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Plays role Antibacterial therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has precise active ingredient Methenamine mandelate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet Has precise active ingredient Monobasic sodium phosphate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start